Englebert Financial Advisers’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Englebert Financial Advisers's ELV Position: Q2 2026 in Review
Englebert Financial Advisers reduced its Elevance Health (ELV) stake by 51% in Q2 2026, selling an estimated $416K and leaving 1,080 shares worth $418K. The position accounts for 0.41% of the portfolio, ranked #46.
Englebert Financial Advisers first reported a position in ELV in Q4 2025 and has held it in 3 quarters since. The position peaked at $687K in Q4 2025. 1,600 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Englebert Financial Advisers held 1,080 shares of Elevance Health worth $418K as of Q2 2026.
- Englebert Financial Advisers sold 1,122 Elevance Health shares in Q2 2026, an estimated $416K.
- Elevance Health made up 0.41% of Englebert Financial Advisers's portfolio in Q2 2026, its #46 holding.
- Englebert Financial Advisers first reported a position in Elevance Health in Q4 2025 and has held it in 3 quarters since.
- Englebert Financial Advisers's Elevance Health position peaked at $687K in Q4 2025.
- 1,600 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Englebert Financial Advisers's 13F filing for Q2 2026, filed 22 Jul 2026.